Zobrazeno 1 - 10
of 6 448
pro vyhledávání: '"demyelinating disease"'
Autor:
Jessica Adriana Kałuża, Oliwia Bochenek, Aleksandra Nowak, Mateusz Koper, Adrian Konaszczuk, Klaudia Ratyna, Oliwia Kozyra, Zofia Szypuła, Katarzyna Paluch, Małgorzata Skarbek
Publikováno v:
Quality in Sport, Vol 21 (2024)
Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune diseases characterized by severe, inflammatory attacks predominantly affecting the optic nerves and spinal cord and central nervous system. NMOSD presents with clinical feature
Externí odkaz:
https://doaj.org/article/5a91d05aa74d497eba09c9a976ecdc0a
Autor:
Guilherme Diogo Silva, João Vitor Mahler, Sérgio Roberto Pereira da Silva Junior, Leonardo Oliveira Mendonça, Pedro Lucas Grangeiro de Sá Barreto Lima, Paulo Ribeiro Nóbrega, Fernando Kok, Fernando Freua
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Monogenic autoinflammatory disorders result in a diverse range of neurological symptoms in adults, often leading to diagnostic delays. Despite the significance of early detection for effective treatment, the neurological manifesta
Externí odkaz:
https://doaj.org/article/10e5297799cc4e468a769967b8fce8f8
Publikováno v:
Clinical Case Reports, Vol 12, Iss 7, Pp n/a-n/a (2024)
Key Clinical Message Accurately identifying fulminant demyelinating diseases is important for sudden onset of asymmetric cerebral white matter lesions with mass effect. Initially, immunotherapy should be administered; however, surgical intervention s
Externí odkaz:
https://doaj.org/article/e92d473398ae4c2980c88f36dc4dc4c3
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesChronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy defined by clinical progression for more than 2 months. 16-20% of CIDP patients may present with rapidly progressive weakness that resembles
Externí odkaz:
https://doaj.org/article/2c9c8d0019e24198b8cc88519802f7d8
Autor:
Xiao-Yu Ji, Yu-Xin Guo, Li-Bin Wang, Wen-Cheng Wu, Jia-Qi Wang, Jin He, Rui Gao, Javad Rasouli, Meng-Yuan Gao, Zhen-Hai Wang, Dan Xiao, Wei-Feng Zhang, Bogoljub Ciric, Yuan Zhang, Xing Li
Publikováno v:
Journal of Neuroinflammation, Vol 21, Iss 1, Pp 1-21 (2024)
Abstract Demyelination and failure of remyelination in the central nervous system (CNS) characterize a number of neurological disorders. Spontaneous remyelination in demyelinating diseases is limited, as oligodendrocyte precursor cells (OPCs), which
Externí odkaz:
https://doaj.org/article/a8e790085cc746e384a6dd3f45614da4
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionIn January 2023, our laboratory began performing serum myelin oligodendrocyte glycoprotein antibody (anti-MOG) titers by fixed cell-based assay (CBA). As a quality assurance (QA) assessment, we evaluated titer positive predictive value (P
Externí odkaz:
https://doaj.org/article/654238eb46704612825764979f9bbad8
Autor:
Hyo Jae Kim, Jong-Eun Park, Wangyong Shin, Dayoung Seo, Seungmi Kim, Hyunji Kim, Jinsung Noh, Yonghee Lee, Hyunjin Kim, Young-Min Lim, Hyori Kim, Eun-Jae Lee
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-11 (2023)
Abstract Background Neuromyelitis optica spectrum disorder (NMOSD) stands out among CNS inflammatory demyelinating diseases (CIDDs) due to its unique disease characteristics, including severe clinical attacks with extensive lesions and its associatio
Externí odkaz:
https://doaj.org/article/ca4ebcd0c418437d8b9c84dbde31178a
Publikováno v:
Journal of IMAB, Vol 29, Iss 2, Pp 4943-4946 (2023)
Purpose: To present a clinical case of tumefactive multiple sclerosis (TMS), which is an inflammatory demyelinating disease of the central nervous system considered to be a rare form of multiple sclerosis (MS). It belongs to the group of borderline f
Externí odkaz:
https://doaj.org/article/8b5a6b4eeedd49c5b262a53ed0fce7a8
Autor:
G. Rynkevič, R. Kizlaitienė
Publikováno v:
Neurologijos seminarai, Vol 27, Iss No. 2 (96) (2024)
Myasthenia gravis (MG) and multiple sclerosis (MS) are thought to have a common autoimmune mechanism as the number of reported co-occurrences of both diseases is increasing. The involvement of both T cells and B cells in the pathogenesis of these two
Externí odkaz:
https://doaj.org/article/1471dadc3af348f6a7e9581f2b9f1bc5